Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence
Objectives To describe the presentation and outcome of SARS-CoV2 infection in an African
setting of high non-communicable co-morbidity and also HIV-1 and tuberculosis prevalence. …
setting of high non-communicable co-morbidity and also HIV-1 and tuberculosis prevalence. …
[HTML][HTML] High resolution imaging and five-year tuberculosis contact outcomes
…, L Macpherson, D Sheerin, S Aziz, K Serole… - medRxiv, 2023 - ncbi.nlm.nih.gov
Methods 250 HIV-uninfected, adult household contacts of rifampicin-resistant TB with a
negative symptom screen underwent baseline 18 F-Fluorodeoxyglucose positron emission and …
negative symptom screen underwent baseline 18 F-Fluorodeoxyglucose positron emission and …
The puzzle of the COVID-19 pandemic in Africa
JM Maeda, JN Nkengasong - Science, 2021 - science.org
The COVID-19 pandemic has been puzzling to many public health experts because Africa
has reported far fewer cases and deaths from COVID-19 than predicted. As of 22 November …
has reported far fewer cases and deaths from COVID-19 than predicted. As of 22 November …
[HTML][HTML] Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
E Du Bruyn, C Stek, R Daroowala… - Nature …, 2023 - nature.com
Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2
infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an …
infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an …
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …